![]() |
![]() |
Legal status
Patent in force
(51) | INT.CL. | C07D 417/14 | (2006.01) |
A61K 31/4439 | (2006.01) | ||
A61P 35/00 | (2006.01) |
(11) | Number of the document | 2331537 |
(13) | Kind of document | T |
(96) | European patent application number | 09782777.8 |
Date of filing the European patent application | 2009-09-08 | |
(97) | Date of publication of the European application | 2011-06-15 |
(45) | Date of publication and mention of the grant of the patent | 2015-10-28 |
(46) | Date of publication of the claims translation | 2016-01-25 |
(86) | Number | PCT/EP2009/061644 |
Date | 2009-09-08 |
(87) | Number | WO 2010/029082 |
Date | 2010-03-18 |
(30) | Number | Date | Country code |
08164104 | 2008-09-10 | EP | |
96674 P | 2008-09-12 | US |
(72) |
CARAVATTI, Giorgio, CH
FAIRHURST, Robin Alec, GB
FURET, Pascal, CH
GUAGNANO, Vito, CH
IMBACH, Patricia, CH
|
(73) |
Novartis AG,
Lichtstrasse 35, 4056 Basel,
CH
|
(74) |
Jurga PETNIŪNAITĖ,
AAA Law, A. Goštauto g. 40B, Verslo centras "Dvyniai", LT-03163 Vilnius,
LT
|
(54) | 1-((5-heteroariltiazol-2-il)aminokarbonil)pirolidin-2-karboksamido dariniai, kaip fosfatidilinozitolio 3-kinazės (PI3K) inhibitoriai, naudingi proliferacinių ligų gydyme |
1-((5-HETEROARYLTHIAZOL-2-YL)AMINOCARBONYL)PYRROLIDINE-2-CARBOXAMIDE DERIVATIVES AS PHOSPHATIDYLINOSITOL 3-KINASE (PI3K) INHIBITORS USEFUL IN THE TREATMENT OF PROLIFERATIVE DISEASES |
Payment date | Validity (years) | Amount | |
2024-08-20 | 16 | 347.00 EUR |
2025-09-08 |